These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 15818058)

  • 1. Limitations of CA125 as an index of peritoneal mesothelial cell mass.
    Breborowicz A; Breborowicz M; Pyda M; Połubinska A; Oreopoulos D
    Nephron Clin Pract; 2005; 100(2):c46-51. PubMed ID: 15818058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer antigen 125: a bulk marker for the mesothelial mass in stable peritoneal dialysis patients.
    Visser CE; Brouwer-Steenbergen JJ; Betjes MG; Koomen GC; Beelen RH; Krediet RT
    Nephrol Dial Transplant; 1995; 10(1):64-9. PubMed ID: 7724031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time to reconsider saline as the ideal rinsing solution during abdominal surgery.
    Połubinska A; Winckiewicz M; Staniszewski R; Breborowicz A; Oreopoulos DG
    Am J Surg; 2006 Sep; 192(3):281-5. PubMed ID: 16920418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
    Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
    Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markers of peritoneal mesothelial cells during treatment with peritoneal dialysis.
    Ho-dac-Pannekeet MM; Hiralall JK; Struijk DG; Krediet RT
    Adv Perit Dial; 1997; 13():17-22. PubMed ID: 9360644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of effluent markers cancer antigen 125, vascular endothelial growth factor, and interleukin-6: relationship with peritoneal transport.
    Rodrigues A; Martins M; Santos MJ; Fonseca I; Oliveira JC; Cabrita A; Melo e Castro J; Krediet RT
    Adv Perit Dial; 2004; 20():8-12. PubMed ID: 15384786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dialysate cell population and cancer antigen 125 in stable continuous ambulatory peritoneal dialysis patients: their relationship with transport parameters.
    Lai KN; Lai KB; Szeto CC; Ho KK; Poon P; Lam CW; Leung JC
    Am J Kidney Dis; 1997 May; 29(5):699-705. PubMed ID: 9159303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in peritoneal mesothelial cells phenotype after chronic exposure to glucose or N-acetylglucosamine.
    Ciszewicz M; Wu G; Tam P; Polubinska A; Breborowicz A
    Transl Res; 2007 Dec; 150(6):337-42. PubMed ID: 18022595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritoneal dialysis with solutions low in glucose degradation products is associated with improved biocompatibility profile towards peritoneal mesothelial cells.
    Witowski J; Korybalska K; Ksiazek K; Wisniewska-Elnur J; Jörres A; Lage C; Schaub TP; Passlick-Deetjen J; Breborowicz A; Grzegorzewska A; Ksiazek A; Liberek T; Lichodziejewska-Niemierko M; Majdan M; Rutkowski B; Stompór T; Sulowicz W
    Nephrol Dial Transplant; 2004 Apr; 19(4):917-24. PubMed ID: 15031350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human peritoneal mesothelial cells are more potent than ovarian cancer cells in producing tumor marker CA-125.
    Zeimet AG; Marth C; Offner FA; Obrist P; Uhl-Steidl M; Feichtinger H; Stadlmann S; Daxenbichler G; Dapunt O
    Gynecol Oncol; 1996 Sep; 62(3):384-9. PubMed ID: 8812537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of CA-125 release by inflammatory cytokines in human peritoneal mesothelial and ovarian cancer cells.
    Zeimet AG; Offner FA; Marth C; Heim K; Feichtinger H; Daxenbichler G; Dapunt O
    Anticancer Res; 1997; 17(4B):3129-31. PubMed ID: 9329618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Necessity of correcting cancer antigen 125 appearance rates by body surface area.
    Kawanishi H; Moriishi M; Harada Y; Sakikubo E; Nagai T; Tsuchiya S
    Adv Perit Dial; 2000; 16():22-5. PubMed ID: 11045255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor.
    Aroeira LS; Aguilera A; Selgas R; Ramírez-Huesca M; Pérez-Lozano ML; Cirugeda A; Bajo MA; del Peso G; Sánchez-Tomero JA; Jiménez-Heffernan JA; López-Cabrera M
    Am J Kidney Dis; 2005 Nov; 46(5):938-48. PubMed ID: 16253736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of cancer antigen 125 and interleukin-15 in relation to the nutrition status of peritoneal dialysis patients.
    Grzegorzewska AE; Mlot M; Leande M
    Adv Perit Dial; 2004; 20():185-9. PubMed ID: 15384823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of cancer antigen 125 by peritoneal mesothelial cells is not influenced by duration of peritoneal dialysis.
    Sanusi AA; Zweers MM; Weening JJ; de Waart DR; Struijk DG; Krediet RT
    Perit Dial Int; 2001; 21(5):495-500. PubMed ID: 11757834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-2-oxothiazolidine-4-carboxylic acid reduces in vitro cytotoxicity of glucose degradation products.
    Breborowicz A; Witowski J; Polubinska A; Pyda M; Oreopoulos D
    Nephrol Dial Transplant; 2004 Dec; 19(12):3005-11. PubMed ID: 15507476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability of effluent cancer antigen 125 and interleukin-6 determination in peritoneal dialysis patients.
    Lopes Barreto D; Coester AM; Noordzij M; Smit W; Struijk DG; Rogers S; de Waart DR; Krediet RT
    Nephrol Dial Transplant; 2011 Nov; 26(11):3739-44. PubMed ID: 21498425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship.
    Carozzi S; Nasini MG; Ravera M; Sanna A; Tirotta A; Lamperi S
    Adv Perit Dial; 1997; 13():7-12. PubMed ID: 9360642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dialysate CA125 in stable CAPD patients: no relation with transport parameters.
    Pannekeet MM; Koomen GC; Struijk DG; Krediet RT
    Clin Nephrol; 1995 Oct; 44(4):248-54. PubMed ID: 8575125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of glucose-free dialysis solutions on human peritoneal mesothelial cells.
    Chang JM; Lin SP; Lai YH; Chen HC
    Am J Nephrol; 2007; 27(2):206-11. PubMed ID: 17377374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.